On May 19, Koninklijke Philips N.V. (NYSE:PHG) introduced VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe, enhancing real-time heart imaging without general anesthesia.

Philips (NYSE: PHG) today announced the first procedures in Europe with its recently launched VeriSight Pro 3D ICE catheter.

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of its VeriSight Pro 3D Intracardiac Echocardiography ...

3D intracardiac echocardiography transducers are in development and in the future may provide an even greater advantage for use in the catheterization laboratory. AO: Aorta; LA: Left atrium ...

CHICAGO, Aug. 13, 2024 /PRNewswire/ -- The global Intracardiac Echocardiography (ICE) Market is expected to grow from USD 333 million in 2024 to USD 545 million by 2029, at a CAGR of 10.3%. Anzeige ...

VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart ...

today announced the introduction of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe. Building on its success in the United States, VeriSight Pro brings real-time 3D ...